围心的多技术方法:将马歇尔乙醇输液和α环切除的直接静脉结合的案例报告
相关实验视频
Updated: Jan 17, 2026

11:21
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
20.1K
Taishi Fukushima1, Yoshihiro Sobue1, Eiichi Watanabe1
1Department of Cardiology, Fujita Health University Bantane Hospital, Nagoya, Aichi, Japan.
Journal of cardiology cases
|September 15, 2025
概括
创新的导管技术,包括阿尔法循环配置和马歇尔乙醇输液的直接静脉,在标准方法失败时成功治疗了复杂的外表膜. 这些方法为具有挑战性的心脏剥离病例提供了替代方案.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗器械 医疗器械
背景情况:
- 周心膜的管理通常涉及复杂的程序,如静脉马歇尔乙醇输液和冠状动脉鼻切除.
- 解剖学上的挑战和先前的干预措施可能会使这些心律失常的标准导管技术复杂化.
研究的目的:
- 报告一例成功治疗双重心跳动,包括使用新的导管技术进行周围心脏动.
- 在标准冠状动脉鼻腔导管和马歇尔乙醇输液静脉失败时强调替代策略.
主要方法:
- 使用阿尔法环导管配置,成功进入冠状动脉鼻.
- 使用马歇尔乙醇输液的直接静脉,通过小光通道导管.
- 进行射频除以终止心跳动脉.
主要成果:
- 阿尔法环导管使冠状动脉鼻通道成功启用.
- 马歇尔乙醇输液直接输入静脉,尽管它并没有单独结束心律失常.
- 结合的方法导致双重心跳动的立即终止.
结论:
- 阿尔法循环方法是挑战冠状动脉鼻接入的有效替代方案.
- 在复杂的情况下,马歇尔乙醇输液的直接,小光线导管式静脉是可行的选择.
- 创新技术对于管理耐火性外心的管理至关重要,特别是在表心参与的情况下.
更多相关视频
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
15.2K
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
1.6K
相关概念视频
Mitral Stenosis III: Medical Management
247
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
247
Mitral Regurgitation III: Medical Management
284
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
284